造影剤の市場規模、シェア、動向分析レポート：モダリティ別、製品別、用途別、投与経路別、最終用途別、地域別、セグメント予測、2025年～2033年

造影剤市場のサマリー

世界の造影剤市場規模は2024年に67億7,000万米ドルと推計され、2033年には138億6,000万米ドルに達すると予測され、2025年から2033年までのCAGRは8.33%で成長します。造影剤の需要は、医療用画像診断の需要増と慢性疾患の負担増によって高まっています。

超音波検査やMRI検査などの画像診断の実施件数が多いことが、市場の成長を支えていると予想されます。医療用画像の世界の需要の高まりは、造影剤市場の拡大を促進する重要な要因です。医療用画像診断は、様々な健康状態の早期発見、正確な診断、効果的な治療計画において重要な役割を果たしています。毎年数百万人の患者がMRI、CTスキャン、X線などの診断処置を受けています。国立医学図書館が2023年10月に発表した研究によると、米国だけでも年間約4,000万件のMRI検査が行われています。世界の画像検査の増加により、これらの検査で体内構造の可視化を高めるために不可欠な造影剤の需要が大幅に高まると予想されます。

米国以外の国々でも、医療用画像診断の需要が高まっています。Australian Institute of Health &Welfare（AIHW）が2024年7月に発表したデータによると、2022-23年にメディケアが補助する画像診断サービスを利用したオーストラリア人は合計1,020万人で、約400万人がその他の診断サービスを利用しました。この増加傾向は今後も続くと予想され、画像診断に使用される造影剤の世界の需要拡大にさらに貢献しています。

さらに、ヨード系造影剤の需要は、より高度な可視化を必要とする画像診断手技の増加に牽引され、大幅に増加しています。いくつかのヨウ素化造影剤は、臨床での採用増加を反映して、力強い収益成長を遂げています。例えば、Bayer AGは2024年に、動脈内および静脈内の両方に使用されるヨードプロミドベースのX線造影剤であるUltravistの顕著な増収を報告しています。このような製品需要の急増は、放射線医学におけるヨード系造影剤の利用が拡大していることを裏付けるものであり、世界の造影剤市場成長の重要な促進要因となっています。

ガドリニウム系造影剤とヨウ素系造影剤の間で多様な分子処方が利用可能であることが、市場成長の原動力となっています。この多様性により、患者のニーズや臨床要件に基づいたオーダーメイドの画像診断が可能となり、診断精度と安全性が向上します。例えば、ガドリニウム系造影剤はMRIに広く使用され、ヨウ素系造影剤はCTに適しています。安全性と有効性を向上させた先進的造影剤の継続的な研究開発は、腫瘍学、循環器学、神経学などの診断用途における市場の拡大をさらに後押ししています。

以下の図では、MRIとCTの用途で一般的に使用されている造影剤を、それぞれのブランド名と分子組成とともに紹介しています。

キーオピニオンリーダー（KOL）

企業名 KOL 成長機会

GEヘルスケアの医薬品診断事業部門世界研究開発責任者であるポール・エヴァンス博士は、「このマンガン系造影剤の第I相試験の結果は心強いものであり、臨床開発プロセスの次のステップを完了することを楽しみにしています。これは、ケアパス全体にわたって患者の転帰を改善することを目的とした当社の製品パイプラインの一部です。"*マンガン系造影剤の登場

• 臨床開発に注力

フレゼニウス・カビUSAの医薬品マーケティング担当上級副社長であり、End Drug Shortage Allianceの取締役会代表であるリンゼイ・トーマス氏は、次のように述べています。「私たちは、この深刻な造影剤不足の状況下で、お客様のお役に立てるよう、空輸を含め、製品の供給を早めるためにできることはすべて行っています。また、米国臨床医が必要不可欠な画像診断を受けられるよう、手頃な価格の造影剤をさらに提供できるよう積極的に取り組んでいます。」*ジェネリック医薬品ポートフォリオの拡大

• サプライチェーン不足への対応
• 手頃な代替品への需要の高まり

GEヘルスケアファーマシューティカル・ダイアグノスティックスの最高医学責任者であるマーク・ヒバードは、次のように述べています。「今回のポートフォリオ拡大により、欧州の多くの国々のお客様に、2つの主要な大環状分子であるクラリスカン（ガドテリック酸）とピキソスキャン（ガドブトロール）を提供できるようになり、放射線科の診断ニーズに合わせてさらに多くの選択肢を提供できるようになります。当社は、ヘルスケア専門家と患者のために、また将来の需要に応えるために、造影剤ポートフォリオの革新と投資を続けています。」*地理的市場への浸透

• 大環状分子によるポートフォリオの拡大

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 造影剤市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• 造影剤市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 造影剤市場：モダリティタイプ別の推定・動向分析

• セグメントダッシュボード
• 世界の造影剤市場：モダリティタイプ別の変動分析
• 世界の造影剤市場規模と動向分析（モダリティタイプ別、2021～2033年）
• 超音波
• 磁気共鳴画像法
• X線/コンピュータ断層撮影

第5章 造影剤市場：製品別の推定・動向分析

• セグメントダッシュボード
• 世界の造影剤市場における製品別の変動分析
• 世界の造影剤市場規模と動向分析（製品別、2021～2033年）
• マイクロバブル
• ガドリニウムベース
• ヨウ素化
• バリウムベース

第6章 造影剤市場：用途別の推定・動向分析

• セグメントダッシュボード
• 世界の造影剤市場の用途別の変動分析
• 世界の造影剤市場規模と動向分析（用途別、2021～2033年）
• 心血管疾患
• 神経疾患
• 胃腸障害
• がん
• 腎臓疾患
• 筋骨格系障害
• その他

第7章 造影剤市場：投与経路別の推定・動向分析

• セグメントダッシュボード
• 世界の造影剤市場の投与経路別の変動分析
• 世界の造影剤市場規模と動向分析（投与経路別、2021～2033年）
• 静脈内
• 経口経路
• 直腸経路

第8章 造影剤デバイス：最終用途別の推定・動向分析

• セグメントダッシュボード
• 世界の造影剤市場の最終用途別の変動分析
• 世界の造影剤市場規模と動向分析（最終用途別、2021～2033年）
• 病院
  • 2021年から2033年までの病院市場推計・予測
• 診断画像センター
  • 2021年から2033年までの診断画像センター市場推計・予測
• その他
  • 2021年から2033年までのその他市場推計・予測

第9章 造影剤市場：地域推定・動向分析（製品別、モダリティ別、用途別、投与経路別、最終用途別）

• 地域ダッシュボード
• 市場規模と予測および動向分析、2021～2033年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • インド
  • 中国
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
  • イノベーター
• ベンダー情勢
  • 主要販売代理店およびチャネルパートナーのリスト
  • Key customers
  • Global Key company market share analysis, 2024
  • Bayer AG
  • GE Healthcare
  • Beijing Beilu Pharmaceutical Co., Ltd.
  • Guerbet
  • Arco Lifesciences（I）Pvt. Ltd.
  • Livealth
  • JB Pharma
  • Blue Jet Healthcare.
  • Bracco Diagnostic, Inc.
  • Fresenius Kabi USA, LLC
  • Voyageur Pharmaceuticals, Ltd
  • Grupo Juste
  • Lantheus Holdings, Inc.
  • iMAX
  • Trivitron Healthcare
  • Jodas Expoim Pvt. Ltd.
• ヒートマップ分析/企業市況分析
• 2024年の企業市場シェア予測分析
• その他の主要市場企業のリスト

List of Tables

• Table 1. List of secondary sources
• Table 2. List of abbreviation
• Table 3. North America contrast media market, by country, 2021 - 2033 (USD Million)
• Table 4. North America contrast media market, by product, 2021 - 2033 (USD Million)
• Table 5. North America contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 6. North America contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 7. North America contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 8. North America contrast media market, by application, 2021 - 2033 (USD Million)
• Table 9. U.S. contrast media market, by product, 2021 - 2033 (USD Million)
• Table 10. U.S. contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 11. U.S. contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 12. U.S. contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 13. U.S. contrast media market, by application, 2021 - 2033 (USD Million)
• Table 14. Canada contrast media market, by product, 2021 - 2033 (USD Million)
• Table 15. Canada contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 16. Canada contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 17. Canada contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 18. Canada contrast media market, by application, 2021 - 2033 (USD Million)
• Table 19. Mexico contrast media market, by product, 2021 - 2033 (USD Million)
• Table 20. Mexico contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 21. Mexico contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 22. Mexico contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 23. Mexico contrast media market, by application, 2021 - 2033 (USD Million)
• Table 24. Europe contrast media market, by country, 2021 - 2033 (USD Million)
• Table 25. Europe contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 26. Europe contrast media market, by product, 2021 - 2033 (USD Million)
• Table 27. Europe contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 28. Europe contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 29. Europe contrast media market, by application, 2021 - 2033 (USD Million)
• Table 30. UK contrast media market, by product, 2021 - 2033 (USD Million)
• Table 31. UK contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 32. UK contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 33. UK contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 34. UK contrast media market, by application, 2021 - 2033 (USD Million)
• Table 35. Germany contrast media market, by product, 2021 - 2033 (USD Million)
• Table 36. Germany contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 37. Germany contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 38. Germany contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 39. Germany contrast media market, by application, 2021 - 2033 (USD Million)
• Table 40. France contrast media market, by product, 2021 - 2033 (USD Million)
• Table 41. France contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 42. France contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 43. France contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 44. France contrast media market, by application, 2021 - 2033 (USD Million)
• Table 45. Italy contrast media market, by product, 2021 - 2033 (USD Million)
• Table 46. Italy contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 47. Italy contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 48. Italy contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 49. Italy contrast media market, by application, 2021 - 2033 (USD Million)
• Table 50. Spain contrast media market, by product, 2021 - 2033 (USD Million)
• Table 51. Spain contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 52. Spain contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 53. Spain contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 54. Spain contrast media market, by application, 2021 - 2033 (USD Million)
• Table 55. Denmark contrast media market, by product, 2021 - 2033 (USD Million)
• Table 56. Denmark contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 57. Denmark contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 58. Denmark contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 59. Denmark contrast media market, by application, 2021 - 2033 (USD Million)
• Table 60. Sweden contrast media market, by product, 2021 - 2033 (USD Million)
• Table 61. Sweden contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 62. Sweden contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 63. Sweden contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 64. Sweden contrast media market, by application, 2021 - 2033 (USD Million)
• Table 65. Norway contrast media market, by product, 2021 - 2033 (USD Million)
• Table 66. Norway contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 67. Norway contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 68. Norway contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 69. Norway contrast media market, by application, 2021 - 2033 (USD Million)
• Table 70. Asia Pacific contrast media market, by country, 2021 - 2033 (USD Million)
• Table 71. Asia Pacific contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 72. Asia Pacific contrast media market, by product, 2021 - 2033 (USD Million)
• Table 73. Asia Pacific contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 74. Asia Pacific contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 75. Asia Pacific contrast media market, by application, 2021 - 2033 (USD Million)
• Table 76. China contrast media market, by product, 2021 - 2033 (USD Million)
• Table 77. China contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 78. China contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 79. China contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 80. China contrast media market, by application, 2021 - 2033 (USD Million)
• Table 81. Japan contrast media market, by product, 2021 - 2033 (USD Million)
• Table 82. Japan contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 83. Japan contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 84. Japan contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 85. Japan contrast media market, by application, 2021 - 2033 (USD Million)
• Table 86. India contrast media market, by product, 2021 - 2033 (USD Million)
• Table 87. India contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 88. India contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 89. India contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 90. India contrast media market, by application, 2021 - 2033 (USD Million)
• Table 91. South Korea contrast media market, by product, 2021 - 2033 (USD Million)
• Table 92. South Korea contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 93. South Korea contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 94. South Korea contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 95. South Korea contrast media market, by application, 2021 - 2033 (USD Million)
• Table 96. Australia contrast media market, by product, 2021 - 2033 (USD Million)
• Table 97. Australia contrast media market, by distribution channel, 2021 - 2033 (USD Million)
• Table 98. Australia contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 99. Australia contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 100. Australia contrast media market, by application, 2021 - 2033 (USD Million)
• Table 101. Thailand contrast media market, by product, 2021 - 2033 (USD Million)
• Table 102. Thailand contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 103. Thailand contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 104. Thailand contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 105. Thailand contrast media market, by application, 2021 - 2033 (USD Million)
• Table 106. Latin America contrast media market, by country, 2021 - 2033 (USD Million)
• Table 107. Latin America contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 108. Latin America contrast media market, by product, 2021 - 2033 (USD Million)
• Table 109. Latin America contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 110. Latin America contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 111. Latin America contrast media market, by application, 2021 - 2033 (USD Million)
• Table 112. Brazil contrast media market, by product, 2021 - 2033 (USD Million)
• Table 113. Brazil contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 114. Brazil contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 115. Brazil contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 116. Brazil contrast media market, by application, 2021 - 2033 (USD Million)
• Table 117. Argentina contrast media market, by product, 2021 - 2033 (USD Million)
• Table 118. Argentina contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 119. Argentina contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 120. Argentina contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 121. Argentina contrast media market, by application, 2021 - 2033 (USD Million)
• Table 122. Middle East & Africa contrast media market, by country, 2021 - 2033 (USD Million)
• Table 123. Middle East & Africa contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 124. Middle East & Africa contrast media market, by product, 2021 - 2033 (USD Million)
• Table 125. Middle East & Africa contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 126. Middle East & Africa contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 127. Middle East & Africa contrast media market, by application, 2021 - 2033 (USD Million)
• Table 128. South Africa contrast media market, by product, 2021 - 2033 (USD Million)
• Table 129. South Africa contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 130. South Africa contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 131. South Africa contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 132. South Africa contrast media market, by application, 2021 - 2033 (USD Million)
• Table 133. Saudi Arabia contrast media market, by product, 2021 - 2033 (USD Million)
• Table 134. Saudi Arabia contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 135. Saudi Arabia contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 136. Saudi Arabia contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 137. Saudi Arabia contrast media market, by application, 2021 - 2033 (USD Million)
• Table 138. UAE contrast media market, by product, 2021 - 2033 (USD Million)
• Table 139. UAE contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 140. UAE contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 141. UAE contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 142. UAE contrast media market, by application, 2021 - 2033 (USD Million)
• Table 143. Kuwait contrast media market, by product, 2021 - 2033 (USD Million)
• Table 144. Kuwait contrast media market, by route of administration, 2021 - 2033 (USD Million)
• Table 145. Kuwait contrast media market, by modality type, 2021 - 2033 (USD Million)
• Table 146. Kuwait contrast media market, by end use, 2021 - 2033 (USD Million)
• Table 147. Kuwait contrast media market, by application, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Contrast Media Market, Market Segmentation
• Fig. 7 Market Driver Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Analysis (Current & Future Impact)
• Fig. 9 Market Opportunity Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Regional Marketplace: Key Takeaways
• Fig. 14 Contrast media market: Modality movement analysis
• Fig. 15 Ultrasound Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 16 Magnetic Resonance Imaging Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 17 X-Ray/Computed Tomography Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 18 Contrast Media Market: Product Movement Analysis
• Fig. 19 Microbubble Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 20 Gadolinium-Based Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 21 Iodinated Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 22 Barium-Based Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 23 Contrast Media Market: Application Movement Analysis
• Fig. 24 Cardiovascular Disorders Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 25 Neurological Disorders Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 26 Cancer Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 27 Gastrointestinal Disorders Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 28 Nephrological Disorders Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 29 Musculoskeletal Disorders Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 30 Gastrointestinal Disorders Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 31 Contrast Media Market: Route Of Administration Movement Analysis
• Fig. 32 Intravenous Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 33 Oral Route Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 34 Rectal Route Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 35 Contrast Media Market: End Use Movement Analysis
• Fig. 36 Hospitals Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 37 Diagnostic Imaging Centers Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 38 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 39 Regional Outlook, 2024 & 2033
• Fig. 40 North America Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 41 U.S. Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 42 Canada Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 43 Mexico Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 44 Europe Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 45 Germany Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 46 UK Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 47 France Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 48 Italy Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 49 Spain Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 50 Denmark Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 51 Sweden Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 52 Norway Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 53 Asia Pacific Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 54 Japan Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 55 China Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 56 India Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 57 Australia Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 58 South Korea Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 59 Thailand Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 60 Latin America Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 61 Brazil Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 62 Argentina Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 63 Middle East and Africa Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 64 South Africa Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 65 Saudi Arabia Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 66 UAE Contrast Media Market, 2021 - 2033 (USD Million)
• Fig. 67 Kuwait Contrast Media Market, 2021 - 2033 (USD Million)

Contrast Media Market Summary

The global contrast media market size was estimated at USD 6.77 billion in 2024 and is projected to reach USD 13.86 billion by 2033, growing at a CAGR of 8.33% from 2025 to 2033. The demand for contrast media is rising owing to the increasing demand for medical imaging and the growing burden of chronic disorders.

High volume of imaging procedures, such as ultrasound and MRI scans, performed is anticipated to support the market growth. The growing global demand for medical imaging is a key factor driving the expansion of the contrast media market. Medical imaging plays a crucial role in the early detection, accurate diagnosis, and effective treatment planning of various health conditions. Millions of patients undergo diagnostic procedures such as MRI, CT scans, and X-rays every year. According to a study published by the National Library of Medicine in October 2023, approximately 40 million MRI scans are performed annually in the U.S. alone. The increasing volume of imaging procedures worldwide is expected to significantly boost the demand for contrast media, essential for enhancing the visualization of internal body structures during these examinations.

Beyond the U.S., other countries are also experiencing a rising demand for medical imaging procedures. According to data published by the Australian Institute of Health & Welfare (AIHW) in July 2024, a total of 10.2 million Australians accessed Medicare-subsidized diagnostic imaging services in 2022-23, while approximately 4.0 million utilized other diagnostic services. This upward trend is expected to continue in the coming years, further contributing to the growing global demand for contrast media used in diagnostic imaging.

Furthermore, the demand for iodinated contrast media is rising significantly, driven by the growing number of imaging procedures requiring enhanced visualization. Several iodinated contrast agents are experiencing strong revenue growth, reflecting increased clinical adoption. For example, in 2024, Bayer AG reported a notable revenue increase from Ultravist, its iopromide-based X-ray contrast agent used for both intra-arterial and intravenous applications. This surge in product demand underscores the expanding utilization of iodinated contrast media in radiology, positioning them as a critical driver in the growth of the global contrast media market.

The availability of diverse molecular formulations among gadolinium-based and iodinated contrast agents drives market growth. This variety allows for tailored imaging based on patient needs and clinical requirements, enhancing diagnostic accuracy and safety. For instance, gadolinium agents are widely used in MRI applications, while iodinated agents are suitable for CT procedures. Continued R&D into advanced contrast media with improved safety and efficacy further supports market expansion across diagnostic applications like oncology, cardiology, and neurology.

The pictorial representation below highlights commonly used contrast agents in MRI and CT applications, along with their respective brand names and molecular compositions.

Key Opinion Leaders

Company Name KOLs Growth Opportunities

Dr Paul Evans, head of global R&D at GE HealthCare's Pharmaceutical Diagnostics business segment "These are encouraging Phase I results for this manganese-based contrast agent, and we look forward to completing the next steps in the clinical development process. This is part of our pipeline of products aiming to improve patient outcomes across care pathways." * Emerging Manganese-Based Contrast Agents

• Focus on Clinical Development

Lindsey Thomas, senior vice president of Pharmaceutical Marketing at Fresenius Kabi USA and the company's representative on the End Drug Shortage Alliance Board of Directors "The U.S. availability of Iodixanol Injection, USP is the first offering from our generic radiology portfolio. We are doing everything we can to accelerate product availability to help our customers during this acute contrast media agent shortage, including air shipping product. We are also actively working to bring additional affordable contrast agents to U.S. clinicians to help ensure patient access to essential diagnostic imaging procedures." * Expansion of Generic Radiology Portfolio

• Addressing Supply Chain Shortages
• Growing Demand for Affordable Alternatives

Mark Hibberd, Chief Medical Officer, GE HealthCare Pharmaceutical Diagnostics "This extension to our portfolio means we will be able to offer two leading macrocyclic molecules-Clariscan (gadoteric acid) and Pixxoscan (gadobutrol)-to our customers in a number of European countries, offering radiology departments even more choice to suit their diagnostic needs. We continue to innovate and invest in our contrast media portfolio to deliver for healthcare professionals and patients and to meet future demand." * Geographic Market Penetration

• Portfolio Expansion with Macrocyclic Molecules

Global Contrast Media Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global contrast media market report based on product, modality type, application, route of administration, end use, and region:

• Modality Outlook (Revenue, USD Million, 2021-2033)
• Ultrasound
• Magnetic Resonance Imaging
• X-ray/Computed Tomography
• Product Outlook (Revenue, USD Million, 2021-2033)
• Microbubble
• Gadolinium-Based
• Iodinated
• Barium-Based
• Application Outlook (Revenue, USD Million, 2021-2033)
• Cardiovascular Disorders
• Neurological Disorders
• Gastrointestinal Disorders
• Cancer
• Nephrological Disorders
• Musculoskeletal Disorders
• Others
• Route of Administration Outlook (Revenue, USD Million, 2021-2033)
• Intravenous
• Oral Route
• Rectal Route
• End Use Outlook (Revenue, USD Million, 2021-2033)
• Hospitals
• Diagnostic Imaging Centers
• Others
• Regional Outlook (Revenue, USD Million, 2021-2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Modality
  • 1.1.3. Application
  • 1.1.4. Route Of Administration
  • 1.1.5. End use
  • 1.1.6. Regional scope
  • 1.1.7. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Contrast Media Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing demand for medical imaging
    • 3.2.1.2. Approvals and launches of contrast media agents
    • 3.2.1.3. Increasing disease burden
    • 3.2.1.4. Technological advancements
    • 3.2.1.5. Rising production capacities for contrast media
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Recalls of contrast media
    • 3.2.2.2. Shortage of Iohexol and Iodixanol
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Development of interconnected solutions in contrast agents
    • 3.2.3.2. Growing number of clinical trials
    • 3.2.3.3. Improvements in public and private healthcare infrastructure
    • 3.2.3.4. Growth potential in emerging economies in contrast media market
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Potential complications and risks associated with contrast media
• 3.3. Contrast Media Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Contrast Media Market: Modality Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Contrast Media Market Modality Type Movement Analysis
• 4.3. Global Contrast Media Market Size & Trend Analysis, by Modality Type, 2021 to 2033 (USD Million)
• 4.4. Ultrasound
  • 4.4.1. Ultrasound market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.5. Magnetic Resonance Imaging
  • 4.5.1. Magnetic resonance imaging market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.6. X-ray/Computed Tomography
  • 4.6.1. X-ray/computed tomography market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. Contrast Media Market: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Contrast Media Market Product Movement Analysis
• 5.3. Global Contrast Media Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 5.4. Microbubble
  • 5.4.1. Microbubble market estimates and forecasts for 2021 to 2033 (USD Million)
• 5.5. Gadolinium-Based
  • 5.5.1. Gadolinium-based market estimates and forecasts for 2021 to 2033 (USD Million)
• 5.6. Iodinated
  • 5.6.1. Iodinated market estimates and forecasts for 2021 to 2033 (USD Million)
• 5.7. Barium-based
  • 5.7.1. Barium-based market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 6. Contrast Media Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Contrast Media Market Application Movement Analysis
• 6.3. Global Contrast Media Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Cardiovascular Disorders
  • 6.4.1. Cardiovascular disorders market estimates and forecast 2021 to 2033 (USD Million)
• 6.5. Neurological Disorders
  • 6.5.1. Neurological disorders market estimates and forecast 2021 to 2033 (USD Million)
• 6.6. Gastrointestinal Disorders
  • 6.6.1. Gastrointestinal disorders market estimates and forecast 2021 to 2033 (USD Million)
• 6.7. Cancer
  • 6.7.1. Cancer market estimates and forecast 2021 to 2033 (USD Million)
• 6.8. Nephrological Disorders
  • 6.8.1. Nephrological disorders market estimates and forecast 2021 to 2033 (USD Million)
• 6.9. Musculoskeletal Disorders
  • 6.9.1. Musculoskeletal disorders market estimates and forecast 2021 to 2033 (USD Million)
• 6.10. Others
  • 6.10.1. Others market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. Contrast Media Market: Route of Administration Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Contrast Media Market Route Of Administration Movement Analysis
• 7.3. Global Contrast Media Market Size & Trend Analysis, by Route Of Administration, 2021 to 2033 (USD Million)
• 7.4. Intravenous
  • 7.4.1. Intravenous market estimates and forecast 2021 to 2033 (USD Million)
• 7.5. Oral Route
  • 7.5.1. Oral route market estimates and forecast 2021 to 2033 (USD Million)
• 7.6. Rectal Route
  • 7.6.1. Rectal route market estimates and forecast 2021 to 2033 (USD Million)

Chapter 8. Contrast Media Devices: End Use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Contrast Media Market End Use Movement Analysis
• 8.3. Global Contrast Media Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 8.4. Hospitals
  • 8.4.1. Hospitals market estimates and forecasts for 2021 to 2033 (USD Million)
• 8.5. Diagnostic Imaging Centers
  • 8.5.1. Diagnostic imaging centers market estimates and forecasts for 2021 to 2033 (USD Million)
• 8.6. Others
  • 8.6.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 9. Contrast Media Market: Regional Estimates & Trend Analysis By Product, By Modality, By Application, By Route of Administration, By End Use

• 9.1. Regional Dashboard
• 9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 9.3. North America
  • 9.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Competitive scenario
    • 9.3.2.3. Regulatory framework
    • 9.3.2.4. Reimbursement scenario
    • 9.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
  • 9.3.3. Canada
    • 9.3.3.1. Key country dynamics
    • 9.3.3.2. Competitive scenario
    • 9.3.3.3. Regulatory framework
    • 9.3.3.4. Reimbursement scenario
    • 9.3.3.5. Canada market estimates and forecasts, 2021 - 2033
  • 9.3.4. Mexico
    • 9.3.4.1. Key country dynamics
    • 9.3.4.2. Competitive scenario
    • 9.3.4.3. Regulatory framework
    • 9.3.4.4. Reimbursement scenario
    • 9.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
• 9.4. Europe
  • 9.4.1. UK
    • 9.4.1.1. Key country dynamics
    • 9.4.1.2. Competitive scenario
    • 9.4.1.3. Regulatory framework
    • 9.4.1.4. Reimbursement scenario
    • 9.4.1.5. UK market estimates and forecasts, 2021 - 2033
  • 9.4.2. Germany
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Competitive scenario
    • 9.4.2.3. Regulatory framework
    • 9.4.2.4. Reimbursement scenario
    • 9.4.2.5. Germany market estimates and forecasts, 2021 - 2033
  • 9.4.3. France
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Competitive scenario
    • 9.4.3.3. Regulatory framework
    • 9.4.3.4. Reimbursement scenario
    • 9.4.3.5. France market estimates and forecasts, 2021 - 2033
  • 9.4.4. Italy
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Competitive scenario
    • 9.4.4.3. Regulatory framework
    • 9.4.4.4. Reimbursement scenario
    • 9.4.4.5. Italy market estimates and forecasts, 2021 - 2033
  • 9.4.5. Spain
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Competitive scenario
    • 9.4.5.3. Regulatory framework
    • 9.4.5.4. Reimbursement scenario
    • 9.4.5.5. Spain market estimates and forecasts, 2021 - 2033
  • 9.4.6. Denmark
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Competitive scenario
    • 9.4.6.3. Regulatory framework
    • 9.4.6.4. Reimbursement scenario
    • 9.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
  • 9.4.7. Sweden
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Competitive scenario
    • 9.4.7.3. Regulatory framework
    • 9.4.7.4. Reimbursement scenario
    • 9.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
  • 9.4.8. Norway
    • 9.4.8.1. Key country dynamics
    • 9.4.8.2. Competitive scenario
    • 9.4.8.3. Regulatory framework
    • 9.4.8.4. Reimbursement scenario
    • 9.4.8.5. Norway market estimates and forecasts, 2021 - 2033
• 9.5. Asia Pacific
  • 9.5.1. Japan
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Competitive scenario
    • 9.5.1.3. Regulatory framework
    • 9.5.1.4. Reimbursement scenario
    • 9.5.1.5. Japan market estimates and forecasts, 2021 - 2033
  • 9.5.2. India
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Competitive scenario
    • 9.5.2.3. Regulatory framework
    • 9.5.2.4. Reimbursement scenario
    • 9.5.2.5. India market estimates and forecasts, 2021 - 2033
  • 9.5.3. China
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Competitive scenario
    • 9.5.3.3. Regulatory framework
    • 9.5.3.4. Reimbursement scenario
    • 9.5.3.5. China market estimates and forecasts, 2021 - 2033
  • 9.5.4. South Korea
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Competitive scenario
    • 9.5.4.3. Regulatory framework
    • 9.5.4.4. Reimbursement scenario
    • 9.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
  • 9.5.5. Australia
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Competitive scenario
    • 9.5.5.3. Regulatory framework
    • 9.5.5.4. Reimbursement scenario
    • 9.5.5.5. Australia market estimates and forecasts, 2021 - 2033
  • 9.5.6. Thailand
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Competitive scenario
    • 9.5.6.3. Regulatory framework
    • 9.5.6.4. Reimbursement scenario
    • 9.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
• 9.6. Latin America
  • 9.6.1. Brazil
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Competitive scenario
    • 9.6.1.3. Regulatory framework
    • 9.6.1.4. Reimbursement scenario
    • 9.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
  • 9.6.2. Argentina
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Competitive scenario
    • 9.6.2.3. Regulatory framework
    • 9.6.2.4. Reimbursement scenario
    • 9.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
• 9.7. MEA
  • 9.7.1. South Africa
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Competitive scenario
    • 9.7.1.3. Regulatory framework
    • 9.7.1.4. Reimbursement scenario
    • 9.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
  • 9.7.2. Saudi Arabia
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Competitive scenario
    • 9.7.2.3. Regulatory framework
    • 9.7.2.4. Reimbursement scenario
    • 9.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
  • 9.7.3. UAE
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Competitive scenario
    • 9.7.3.3. Regulatory framework
    • 9.7.3.4. Reimbursement scenario
    • 9.7.3.5. UAE market estimates and forecasts, 2021 - 2033
  • 9.7.4. Kuwait
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Competitive scenario
    • 9.7.4.3. Regulatory framework
    • 9.7.4.4. Reimbursement scenario
    • 9.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Company/Competition Categorization
  • 10.2.1. Innovators
• 10.3. Vendor Landscape
  • 10.3.1. List of key distributors and channel partners
  • 10.3.2. Key customers
  • 10.3.3. Global Key company market share analysis, 2024
  • 10.3.4. Bayer AG
    • 10.3.4.1. Company overview
    • 10.3.4.2. Financial performance
    • 10.3.4.3. Product benchmarking
    • 10.3.4.4. Strategic initiatives
  • 10.3.5. GE Healthcare
    • 10.3.5.1. Company overview
    • 10.3.5.2. Financial performance
    • 10.3.5.3. Product benchmarking
    • 10.3.5.4. Strategic initiatives
  • 10.3.6. Beijing Beilu Pharmaceutical Co., Ltd.
    • 10.3.6.1. Company overview
    • 10.3.6.2. Financial performance
    • 10.3.6.3. Product benchmarking
    • 10.3.6.4. Strategic initiatives
  • 10.3.7. Guerbet
    • 10.3.7.1. Company overview
    • 10.3.7.2. Financial performance
    • 10.3.7.3. Product benchmarking
    • 10.3.7.4. Strategic initiatives
  • 10.3.8. Arco Lifesciences (I) Pvt. Ltd.
    • 10.3.8.1. Company overview
    • 10.3.8.2. Financial performance
    • 10.3.8.3. Product benchmarking
    • 10.3.8.4. Strategic initiatives
  • 10.3.9. Livealth
    • 10.3.9.1. Company overview
    • 10.3.9.2. Financial performance
    • 10.3.9.3. Product benchmarking
    • 10.3.9.4. Strategic initiatives
  • 10.3.10. JB Pharma
    • 10.3.10.1. Company overview
    • 10.3.10.2. Financial performance
    • 10.3.10.3. Product benchmarking
    • 10.3.10.4. Strategic initiatives
  • 10.3.11. Blue Jet Healthcare.
    • 10.3.11.1. Company overview
    • 10.3.11.2. Financial performance
    • 10.3.11.3. Product benchmarking
    • 10.3.11.4. Strategic initiatives
  • 10.3.12. Bracco Diagnostic, Inc.
    • 10.3.12.1. Company overview
    • 10.3.12.2. Financial performance
    • 10.3.12.3. Product benchmarking
    • 10.3.12.4. Strategic initiatives
  • 10.3.13. Fresenius Kabi USA, LLC
    • 10.3.13.1. Company overview
    • 10.3.13.2. Financial performance
    • 10.3.13.3. Product benchmarking
    • 10.3.13.4. Strategic initiatives
  • 10.3.14. Voyageur Pharmaceuticals, Ltd
    • 10.3.14.1. Company overview
    • 10.3.14.2. Financial performance
    • 10.3.14.3. Product benchmarking
    • 10.3.14.4. Strategic initiatives
  • 10.3.15. Grupo Juste
    • 10.3.15.1. Company overview
    • 10.3.15.2. Financial performance
    • 10.3.15.3. Product benchmarking
    • 10.3.15.4. Strategic initiatives
  • 10.3.16. Lantheus Holdings, Inc.
    • 10.3.16.1. Company overview
    • 10.3.16.2. Financial performance
    • 10.3.16.3. Product benchmarking
    • 10.3.16.4. Strategic initiatives
  • 10.3.17. iMAX
    • 10.3.17.1. Company overview
    • 10.3.17.2. Financial performance
    • 10.3.17.3. Product benchmarking
    • 10.3.17.4. Strategic initiatives
  • 10.3.18. Trivitron Healthcare
    • 10.3.18.1. Company overview
    • 10.3.18.2. Financial performance
    • 10.3.18.3. Product benchmarking
    • 10.3.18.4. Strategic initiatives
  • 10.3.19. Jodas Expoim Pvt. Ltd.
    • 10.3.19.1. Company overview
    • 10.3.19.2. Financial performance
    • 10.3.19.3. Product benchmarking
    • 10.3.19.4. Strategic initiatives
• 10.4. Heat Map Analysis/ Company Market Position Analysis
• 10.5. Estimated Company Market Share Analysis, 2024
• 10.6. List of Other Key Market Players